Schedule 13G ownership disclosure

Rapport Therapeutics Inc

Security class unavailable · CUSIP: 75383L102

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-24-000885
Form type
SC 13G
Filer
ARCH Venture Fund XII, L.P.
CIK
CIK 1906837
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub